Cagrilintide (AM833) Long acting amylin analog. Beta cells make TWO hormones: insulin and amylin. Amylin slows stomach emptying and reduces appetite. Cagrilintide is a long acting synthetic amylin designed for once weekly dosing Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial ScienceDirect Zealand Pharma CEO says Novo's CagriSema data supports monotherapy approach to cagrilintide PharmaLive Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug Cagrilintide 10mg Valar Peptides Cagrilintide Research Peptide Information Peptpedia